NeurogesX

Develops and commercializes therapies for chronic peripheral neuropathic pain.

Launch date

1998

Employees

Market cap

Enterprise valuation

San Carlos California (HQ)

http://neurogesx.com

Date	Investors	Amount	Round
Jun 2000	Alta Partners Montreux Equity Partners ARCH Venture Partners Grove Street Advisors TIAA	$8.4m	Series A
Jan 2002	Walden International Alta Partners Montreux Equity Partners ARCH Venture Partners Grove Street Advisors TIAA	$22.9m	Series B
Feb 2004	Global Life Science Ventures Walden International Alta Partners Montreux Equity Partners ARCH Venture Partners TIAA Diamond Capital Management	$35.0m	Series C
Dec 2005	Global Life Science Ventures Walden International Alta Partners Montreux Equity Partners ARCH Venture Partners	$20.0m	Series D
May 2007	N/A	N/A	IPO
Jan 2008	SV Health Investors	$25.0m	Post IPO Equity
Aug 2011	SV Health Investors	$20.2m	Post IPO Equity
Mar 2012	N/A	$980k	Seed
Jul 2013*	Acorda Therapeutics	N/A	Acquisition
Total Funding		€79.3m

Tech stackLearn more about the technologies and tools that this company uses.